---
figid: PMC6040288__ECAM2018-5194016.009
figtitle: 'Network pathway: pathway enrichment analysis was performed'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6040288
filename: ECAM2018-5194016.009.jpg
figlink: /pmc/articles/PMC6040288/figure/fig9/
number: F9
caption: 'Network pathway: pathway enrichment analysis was performed. 97 filtered
  target genes were mapped into Alzheimer''s disease pathway from the Kyoto Encyclopedia
  of Genes and Genomes (KEGG) to confirm the possible effect pathway of Acori Tatarinowii
  Rhizoma (ATR) on Alzheimer''s disease.'
papertitle: Systems Pharmacological Approach to Investigate the Mechanism of Acori
  Tatarinowii Rhizoma for Alzheimer's Disease.
reftext: Zhenyan Song, et al. Evid Based Complement Alternat Med. 2018;2018:5194016.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8977754
figid_alias: PMC6040288__F9
figtype: Figure
redirect_from: /figures/PMC6040288__F9
ndex: 1f05a213-ded3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6040288__ECAM2018-5194016.009.html
  '@type': Dataset
  description: 'Network pathway: pathway enrichment analysis was performed. 97 filtered
    target genes were mapped into Alzheimer''s disease pathway from the Kyoto Encyclopedia
    of Genes and Genomes (KEGG) to confirm the possible effect pathway of Acori Tatarinowii
    Rhizoma (ATR) on Alzheimer''s disease.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - app
  - Appl
  - ApepP
  - APP-BP1
  - ab
  - Ass
  - ca
  - ATPsynbeta
  - Atpalpha
  - cav
  - ap
  - Fadd
  - Dark
  - Oamb
  - fo
  - Nos
  - nos
  - egr
  - Rbp9
  - casp
  - en
  - Sap-r
  - Lip2
  - cu
  - P-25
  - Cdk5alpha
  - DCTN5-p25
  - cas
  - caz
  - Cse1
  - cass
  - cash
  - APP
  - SUCLA2
  - CA1
  - LPL
  - LCP1
  - APOE
  - ASS1
  - ATP8A2
  - EIF4A3
  - FALEC
  - CA5A
  - CAV2
  - CAV1
  - CAV3
  - FADD
  - BID
  - CALM2
  - CALM3
  - PICALM
  - SNAP91
  - CALM1
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - CACNA1A
  - CACNA1B
  - CACNA1C
  - CACNA1D
  - CACNA1E
  - CACNA1F
  - CACNA1G
  - CACNA1H
  - CACNA1I
  - CACNA1S
  - CACNA2D1
  - CACNA2D2
  - CACNA2D3
  - CACNA2D4
  - CACNB1
  - CACNB2
  - CACNB3
  - CACNB4
  - CACNG1
  - CACNG2
  - CACNG3
  - CACNG4
  - CACNG5
  - CACNG6
  - CACNG7
  - CACNG8
  - NOS1
  - NOS2
  - NOS3
  - THAS
  - TNF
  - FES
  - RTN4
  - APOL1
  - APOBEC1
  - FAS
  - HSD17B10
  - CUX1
  - CYTIP
  - CRTAP
  - ENPEP
  - ANXA2
  - ANXA2P3
  - MRPL17
  - LCN2
  - CDK5R1
  - TPPP
  - TMED9
  - CSE1L
  - CTNND1
  - BCAR1
  - TMX2-CTNND1
  - ATP
  - Tau-P
  - Aleheimers disease
  - SINI
  - Mitochondrial dysfunction
---
